Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Autoimmune Demyelinating Disease, Peripheral

3-iodobenzylguanidine has been researched along with Autoimmune Demyelinating Disease, Peripheral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gen, H; Himura, Y; Iga, K; Izumi, C; Kijima, K; Konishi, T; Miyamoto, T1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Autoimmune Demyelinating Disease, Peripheral

ArticleYear
Reversible left ventricular dysfunction associated with Guillain-Barré syndrome--an expression of catecholamine cardiotoxicity?
    Japanese circulation journal, 1995, Volume: 59, Issue:4

    Topics: 3-Iodobenzylguanidine; Aged; Catecholamines; Female; Follow-Up Studies; Humans; Iodobenzenes; Nerve Endings; Polyradiculoneuropathy; Sympathetic Nervous System; Ventricular Dysfunction, Left

1995